Medical and neurobehavioural phenotypes in carriers of X-linked ichthyosis-associated genetic deletions in the UK Biobank.
Adult
Aged
Arrhythmias, Cardiac
/ complications
Biological Specimen Banks
Female
Gene Deletion
Genetic Association Studies
Genetic Predisposition to Disease
Heterozygote
Humans
Ichthyosis, X-Linked
/ complications
Male
Mental Disorders
/ complications
Middle Aged
Phenotype
Skin
/ pathology
Steryl-Sulfatase
/ genetics
Surveys and Questionnaires
United Kingdom
/ epidemiology
arrhythmias
copy-number
dermatology
neurosciences
psychiatry
Journal
Journal of medical genetics
ISSN: 1468-6244
Titre abrégé: J Med Genet
Pays: England
ID NLM: 2985087R
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
05
11
2019
revised:
20
12
2019
accepted:
23
01
2020
pubmed:
7
3
2020
medline:
9
7
2021
entrez:
7
3
2020
Statut:
ppublish
Résumé
X-linked ichthyosis (XLI) is an uncommon dermatological condition resulting from a deficiency of the enzyme steroid sulfatase (STS), often caused by X-linked deletions spanning Using the UK Biobank resource, comprising participants aged 40-69 years recruited from the general UK population, we compared multiple medical/neurobehavioural phenotypes in males (n=86) and females (n=312) carrying genetic deletions spanning We identified an elevated rate of atrial fibrillation/flutter in male deletion carriers (10.5% vs 2.7% in male controls, Benjamini-Hochberg corrected p=0.009), and increased rates of mental distress (p=0.003), irritability (p<0.001) and depressive-anxiety traits (p<0.05) in male deletion carriers relative to male controls completing the Mental Health Questionnaire. While academic attainment was unaffected, male and female deletion carriers exhibited impaired performance on the Fluid Intelligence Test (Cohen's d≤0.05, corrected p<0.1). Neuroanatomical analysis in female deletion carriers indicated reduced right putamen and left nucleus accumbens volumes (Cohen's d≤0.26, corrected p<0.1). Adult males with XLI disease-causing deletions are apparently at increased risk of cardiac arrhythmias and self-reported mood problems; altered basal ganglia structure may underlie altered function and XLI-associated psychiatric/behavioural phenotypes. These results provide information for genetic counselling of deletion-carrying individuals and reinforce the need for multidisciplinary medical care.
Sections du résumé
BACKGROUND
X-linked ichthyosis (XLI) is an uncommon dermatological condition resulting from a deficiency of the enzyme steroid sulfatase (STS), often caused by X-linked deletions spanning
METHODS
Using the UK Biobank resource, comprising participants aged 40-69 years recruited from the general UK population, we compared multiple medical/neurobehavioural phenotypes in males (n=86) and females (n=312) carrying genetic deletions spanning
RESULTS
We identified an elevated rate of atrial fibrillation/flutter in male deletion carriers (10.5% vs 2.7% in male controls, Benjamini-Hochberg corrected p=0.009), and increased rates of mental distress (p=0.003), irritability (p<0.001) and depressive-anxiety traits (p<0.05) in male deletion carriers relative to male controls completing the Mental Health Questionnaire. While academic attainment was unaffected, male and female deletion carriers exhibited impaired performance on the Fluid Intelligence Test (Cohen's d≤0.05, corrected p<0.1). Neuroanatomical analysis in female deletion carriers indicated reduced right putamen and left nucleus accumbens volumes (Cohen's d≤0.26, corrected p<0.1).
CONCLUSION
Adult males with XLI disease-causing deletions are apparently at increased risk of cardiac arrhythmias and self-reported mood problems; altered basal ganglia structure may underlie altered function and XLI-associated psychiatric/behavioural phenotypes. These results provide information for genetic counselling of deletion-carrying individuals and reinforce the need for multidisciplinary medical care.
Identifiants
pubmed: 32139392
pii: jmedgenet-2019-106676
doi: 10.1136/jmedgenet-2019-106676
pmc: PMC7525778
doi:
Substances chimiques
Steryl-Sulfatase
EC 3.1.6.2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
692-698Subventions
Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 201171/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Circ Arrhythm Electrophysiol. 2014 Apr;7(2):307-12
pubmed: 24610804
Brain Res. 2001 Dec 20;922(2):216-22
pubmed: 11743952
Exp Dermatol. 2019 Oct;28(10):1156-1163
pubmed: 29672931
J Clin Endocrinol Metab. 2016 Jun;101(6):2545-53
pubmed: 27003302
Circ Genom Precis Med. 2019 Feb;12(2):e002419
pubmed: 30649896
J Am Acad Dermatol. 2015 Apr;72(4):617-27
pubmed: 25659225
Eur J Prev Cardiol. 2014 Mar;21(3):291-8
pubmed: 23152363
Genes Brain Behav. 2011 Apr;10(3):334-44
pubmed: 21255266
Prenat Diagn. 2010 Sep;30(9):893-8
pubmed: 20715120
J Dermatol. 2018 Oct;45(10):e275-e276
pubmed: 29569268
Br J Dermatol. 1998 Apr;138(4):655-7
pubmed: 9640374
Clin Epidemiol. 2014 Jun 16;6:213-20
pubmed: 24966695
Brain Res. 1973 Sep 14;59:349-58
pubmed: 4747761
Lancet. 1983 Dec 24-31;2(8365-66):1456
pubmed: 6140547
Front Physiol. 2018 Oct 04;9:1380
pubmed: 30337881
Mol Autism. 2014 Mar 06;5(1):21
pubmed: 24602487
PLoS One. 2019 Feb 15;14(2):e0212330
pubmed: 30768640
Psychoneuroendocrinology. 2016 Dec;74:363-370
pubmed: 27728876
Psychoneuroendocrinology. 2012 Feb;37(2):221-9
pubmed: 21723668
Lancet Psychiatry. 2017 Apr;4(4):310-319
pubmed: 28219628
Neuroimage. 2018 Feb 1;166:400-424
pubmed: 29079522
J Med Genet. 2008 Aug;45(8):519-24
pubmed: 18413370
Genome Res. 2007 Nov;17(11):1665-74
pubmed: 17921354
Prog Brain Res. 2008;172:423-63
pubmed: 18772045
Psychoneuroendocrinology. 2013 Aug;38(8):1370-80
pubmed: 23276394
Biol Psychiatry. 2009 Aug 15;66(4):360-7
pubmed: 19251250
Neuropsychopharmacology. 2014 Oct;39(11):2622-32
pubmed: 24842408
Neuron. 2019 Aug 7;103(3):445-458.e10
pubmed: 31202541
J Am Acad Dermatol. 2010 Mar;62(3):480-5
pubmed: 20080321
Br J Dermatol. 2018 Oct;179(4):933-939
pubmed: 29901853
Am J Epidemiol. 2017 Nov 1;186(9):1026-1034
pubmed: 28641372
Biol Psychiatry. 2017 Jul 15;82(2):103-110
pubmed: 27773354
Neuropsychopharmacology. 2008 Sep;33(10):2398-406
pubmed: 18046307
Prenat Diagn. 2009 Oct;29(10):966-74
pubmed: 19609942
PLoS One. 2014 Apr 03;9(4):e93623
pubmed: 24699871
PLoS One. 2016 Oct 6;11(10):e0164417
pubmed: 27711218
J Dermatol. 2016 Mar;43(3):242-51
pubmed: 26945532
Neuropsychopharmacology. 2012 Apr;37(5):1267-74
pubmed: 22189290
J Intern Med. 2019 Oct;286(4):389-397
pubmed: 31283063
Exp Gerontol. 2002 May;37(5):701-12
pubmed: 11909687
Am J Psychiatry. 2018 Apr 1;175(4):359-369
pubmed: 29145754
J Med Case Rep. 2017 Sep 22;11(1):267
pubmed: 28934990
Acta Derm Venereol. 1999 Mar;79(2):143-4
pubmed: 10228635